HIGHLIGHTS
- who: Liyong Shi and colleagues from the National Hospital Organization Kyoto Medical Center, Japan Medical University, Quanzhou, China have published the research work: Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure, in the Journal: (JOURNAL)
- future: Due to the limited number of cases TMB and PD-L1 expression cannot yet be used as independent predictors of prognosis and therefore further studies and exploration are required.
SUMMARY
Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT), an aggressive and rare malignancy, is characterized by SMARCA4 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.